Case report · 2019
Research articlePublished 2016
Hyponatremia: A Potential Prognostic Biomarker in Malignant Pleural Mesothelioma?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives Malignant pleural mesothelioma (MPM) remains an incurable and with very poor outcome cancer. The median survival is 12 months with first line therapy; a median survival of 24 months at best when treated with multimodal approach (both neoadjuvant chemotherapy and surgery with or without radiation therapy or postoperative chemotherapy). Identifying a possible prognostic marker would seem imperative. Several studies, all with limited numbers of patients, have tried to find a possible valid and reliable prognostic marker. Univariate and multivariate analyses had been performed, yet the majority of the findings remain invalidated in other MPM populations. It has been recently shown that a reduction in serum sodium could have negative effects on hospitalization length, quality of life and prognosis in cancer patients. Materials and methods We therefore performed a retrospective single institute analysis to assess and possibly confirm the prognostic role of hyponatremia in MPM. Results The OS and the PFS in the hyponatremia group are inferior to the patients who had normal serum sodium level throughout the treatment. None of our patients presented with hyponatremia, but having sodium serum level <130 at some point during chemotherapy was a strong indicator of short PFS and a negative prognostic factor. The findings were similar in first and second line setting. Conclusion Further prospective, well designed trial, are warranted to better explore the impact of sodium correction on the PFS and OS of cancer patients and MPM.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Other · 22 Jul 2016
Pemetrexed in the treatment of malignant pleural mesothelioma
Review article · 7 Jul 2016
Treatment of malignant pleural mesothelioma: current status and future directions
Research article · 29 Oct 2020
Evaluation of the Prognostic Value of the Prechemotherapy Platelet to Lymphocyte Ratio in Malignant Pleural Mesothelioma
Other · Aug 2011
Pleural, Peritoneal and Pericardial Mesothelioma. Case report of autopsy
More from this journal
The newest in Journal of General Practice.
Brief report · 29 Dec 2025
Comprehensive Geriatric Care: A General Practice Blueprint
Brief report · 29 Dec 2025
Integrating Women’s Health into Primary Care for Better Outcomes
Short communication · 29 Dec 2025
Family Physicians: Pillars of Comprehensive Child Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of General Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Hudson Z”
- BylineArticles whose byline prints “Grosso F”
- BylineArticles whose byline prints “Comins C”
- BylineArticles whose byline prints “Alfredo Addeo”

